关注
Renaud Loïc
Renaud Loïc
在 gustaveroussy.fr 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
S Poulain, C Roumier, E Bertrand, A Renneville, A Caillault-Venet, ...
Clinical Cancer Research 23 (20), 6325-6335, 2017
742017
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
MR Wilson, TA Eyre, AA Kirkwood, N Wong Doo, C Soussain, S Choquet, ...
Blood, The Journal of the American Society of Hematology 139 (16), 2499-2511, 2022
612022
Discovery of candidate DNA methylation cancer driver genes
H Pan, L Renaud, R Chaligne, J Bloehdorn, E Tausch, D Mertens, ...
Cancer discovery 11 (9), 2266-2281, 2021
502021
Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature …
A Leurs, V Gnemmi, A Lionet, L Renaud, JB Gibier, MC Copin, E Hachulla, ...
Frontiers in immunology 10, 1489, 2019
312019
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
C Herbaux, C Kornauth, S Poulain, SJF Chong, MC Collins, R Valentin, ...
Blood, The Journal of the American Society of Hematology 137 (25), 3495-3506, 2021
272021
Pomalidomide for multiple myeloma
G Fouquet, C Bories, S Guidez, L Renaud, C Herbaux, S Javed, T Facon, ...
Expert Review of Hematology 7 (6), 719-731, 2014
262014
Response to pneumococcal vaccination in multiple myeloma
L Renaud, S Schraen, G Fouquet, S Guidez, H Demarquette, M Nudel, ...
Cancer Medicine 8 (8), 3822-3830, 2019
242019
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
L Renaud, JB Bossard, B Carpentier, L Terriou, N Cambier, G Chanteau, ...
European Journal of Haematology 107 (3), 2021
212021
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: a prospective cohort
Z Van de Wyngaert, C Berthon, H Debarri, C Bories, S Bonnet, M Nudel, ...
International journal of antimicrobial agents 53 (6), 781-788, 2019
212019
Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
S Bernard, H Ghesquieres, RO Casasnovas, S Griolet, M Gomes da Silva, ...
Blood Advances 5 (15), 2965-2968, 2021
92021
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: a study of the French Hauts-de-France AML observatory
A RUNX
82019
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adults with primary mediastinal B cells lymphoma (PMBCL): a retrospective study on behalf of the …
B Le Calvez, B Tessoulin, L Renaud, C Botella-Garcia, M Srour, ...
Blood 138, 1826, 2021
7*2021
Heavy+ light chain analysis to assign myeloma response is analogous to the IMWG response criteria
G Fouquet, KIE Snell, S Guidez, S Schraen, E Boyle, L Renaud, ...
Leukemia & lymphoma 59 (3), 583-589, 2018
72018
De novo and secondary acute myeloid leukemia, real world data on outcomes from the French Nord-Pas-De-Calais Picardie acute myeloid leukemia observatory
L Renaud, O Nibourel, C Berthon, C Roumier, C Rodriguez, C Frimat, ...
Blood, The Journal of the American Society of Hematology 128 (22), 4013-4013, 2016
62016
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial
L Brugières, N Cozic, R Houot, C Rigaud, D Sibon, J Arfi-Rouche, ...
European Journal of Cancer 191, 112984, 2023
52023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
C Thieblemont, B Altmann, F Frontzek, L Renaud, L Chartier, N Ketterer, ...
Blood Advances 7 (15), 3968-3977, 2023
42023
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials
SJ Juul, S Rossetti, M Kicinski, MAE van der Kaaij, F Giusti, P Meijnders, ...
Acta Oncologica 62 (7), 744-752, 2023
42023
Le pomalidomide dans le myélome multiple
G Fouquet, M Macro, O Decaux, C Fohrer, S Guidez, H Demarquette, ...
La Revue de Médecine Interne 36 (9), 613-618, 2015
42015
Les gammapathies monoclonales de signification indéterminée ne nécessitent pas systématiquement un recours à une consultation spécialisée
G Fouquet, K Amouzou, L Renaud, B Carpentier, A Simonnet, ...
La Revue de médecine interne 36 (7), 444-449, 2015
42015
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials
SJ Juul, S Rossetti, M Kicinski, MAE van der Kaaij, F Giusti, P Meijnders, ...
Journal of Cancer Survivorship 18 (3), 727-738, 2024
32024
系统目前无法执行此操作,请稍后再试。
文章 1–20